PASITHEA THERAPEUTICS CORP. Payments for Repurchase of Private Placement
PASITHEA THERAPEUTICS CORP. (KTTA) reported Payments for Repurchase of Private Placement of $1.00 million for the 12-month period ending 2021-12-31, per its 10-Q filed 2022-11-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRepurchaseOfPrivatePlacement · last filed 2022-11-14
- PASITHEA THERAPEUTICS CORP. payments for repurchase of private placement for the quarter ending 2021-12-31 was -$4.00M.
- PASITHEA THERAPEUTICS CORP. payments for repurchase of private placement for the quarter ending 2021-03-31 was $1.00M.
| Period end | Payments for Repurchase of Private Placement 1 month | Payments for Repurchase of Private Placement 3 month | Payments for Repurchase of Private Placement 9 month | Payments for Repurchase of Private Placement 12 month |
|---|---|---|---|---|
| 2021-12-31 | -$4.00M derived: 10-Q 12 month − 10-Q 9 month · filed 2022-11-14 | $1.00M 10-Q · filed 2022-11-14 | ||
| 2021-09-30 | $5.00M 10-Q · filed 2021-11-18 | |||
| 2021-03-31 | $1.00M 10-Q · filed 2021-11-18 | |||
| 2021-01-31 | $1.00M 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |